首页> 外文期刊>Substance Abuse Treatment, Prevention, and Policy >“Nonmedical” prescription opioid use in North America: a call for priority action
【24h】

“Nonmedical” prescription opioid use in North America: a call for priority action

机译:北美“非医疗”处方阿片类药物的使用:呼吁采取优先行动

获取原文
       

摘要

Nearly four years after the United States Congress heralded a “decade of pain control and research”, chronic pain remains a mounting public health concern worldwide. The escalating prevalence of chronic pain in recent years has been paralleled by a rise in prescription opioid availability, misuse, and associated human and social costs. However, national monitoring surveys in the U.S. and Canada currently fail to differentiate between prescription opioid misuse for the purposes of euphoria versus pain or withdrawal management. Furthermore, there is a lack of evidence-based guidelines for pain management among high-risk individuals, and a glaring lack of education for practitioners in the areas of pain and addiction medicine. Herein we propose multiple avenues for intervention and research in order to mitigate the individual, social and structural problems related to undertreated pain and prescription opioid misuse.
机译:在美国国会宣布“疼痛控制和研究十年”将近四年之后,慢性疼痛仍是全球公众日益关注的健康问题。近年来,慢性疼痛的患病率不断上升,同时处方阿片类药物的可获得性,滥用和相关的人类与社会成本也在增加。但是,目前在美国和加拿大进行的国家监测调查无法区分出于兴奋和止痛或停药管理而滥用处方阿片类药物的情况。此外,在高危人群中缺乏基于证据的疼痛管理指南,并且在疼痛和成瘾医学领域对从业人员缺乏明确的教育。本文中,我们提出了多种干预和研究途径,以减轻与治疗不足的疼痛和处方阿片类药物滥用有关的个人,社会和结构问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号